Levofloxacin

Levofloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes that are essential for DNA replication and transcription. By inhibiting these enzymes, the drug prevents bacterial cells from duplicating their genetic material, leading to bacterial death and resolution of the infection.

The dosage of Levofloxacin is individualized by the treating physician based on the infection type, severity, patient age, renal function, and other clinical factors. Only a qualified prescriber can determine the appropriate dose and treatment duration.

Levofloxacin’s pregnancy category is listed as unknown, and safety data are limited. It should only be used during pregnancy or lactation when the potential benefit justifies any potential risk to the fetus or infant, and after a careful risk‑benefit assessment by the healthcare provider.

To request Levofloxacin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Levofloxacin is a third‑generation fluoroquinolone offering broad‑spectrum activity against Gram‑positive and Gram‑negative bacteria. Compared with older fluoroquinolones, it provides once‑daily dosing and enhanced activity against respiratory pathogens, but it shares class‑related safety considerations such as tendon toxicity and QT prolongation.

Levofloxacin tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keeping the product in a dry, cool place helps maintain its potency throughout its shelf life.

Levofloxacin is supplied as an oral tablet and is taken by mouth with or without food, as directed by the prescriber. The tablet should be swallowed whole with a full glass of water and not crushed or chewed unless specifically instructed.

Serious risks include tendon rupture, especially in the Achilles tendon, QT interval prolongation leading to arrhythmias, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated diarrhea, peripheral neuropathy, and hepatic injury. Patients should be advised to seek immediate medical attention if they experience any of these symptoms.

Levofloxacin is contraindicated in patients with a known hypersensitivity to fluoroquinolones or any of the tablet’s excipients. It should also be avoided in individuals with a history of tendon disorders related to fluoroquinolone use, and used with caution in patients with cardiac arrhythmias, uncontrolled epilepsy, or severe renal impairment.